TickerFactsScreenerDevelopers

Spero Therapeutics, Inc. (SPRO) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2015: $232.0K2016: $830.0K2017: $27.0K2018: $2.44M2019: $314.0K2020: $157.0K$157.0K
2015Capital Expenditures (USD)2020
Fiscal YearCapital ExpendituresChange YoY
2020$157.0K-50.0%
2019$314.0K-87.1%
2018$2.44M+8922.2%
2017$27.0K-96.7%
2016$830.0K+257.8%
2015$232.0K—